PharmTech Drug Digest 11.20
|Articles|July 29, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-08-06-2014
  • Volume 10
  • Issue 8

I Holland Launches New Packaging Solution to Eliminate Potential Tool Tip Damage

PrimePac tubes, part of the company's new portfolio of packaging, have been specifically designed with a safety zone to hold tablet punches in position to stop damage to the tip face.

I Holland, a specialist manufacturer of tablet tooling for the pharmaceutical and nutraceutical industries, has released a new packaging solution to ensure its products arrive in perfect condition. PrimePac tubes (patent pending), part of the company’s new portfolio of packaging, have been specifically designed with a safety zone to hold tablet punches in position to stop damage to the tip face.

Michael Oxford, R&D engineer, I Holland, notes that one of the most important and fundamental problems when transporting tablet tooling is ensuring that the punch tip face is undamaged. “Any damage to the very delicate land area will result in reduction of punch life when the punch is placed under stress in operation,” he explains.

“Although our previous packaging tubes have served us well, we felt that re-designing them to incorporate an innovative safety zone ensures the quality of the product, knowing that it will arrive with the customer in the same quality condition that it left the factory,” Oxford continues. “By designing the PrimePac range, we can maintain our customer service and ensure the end user receives the best quality product available, something very important to I Holland.”

Current methods of packaging protection commonly used by punch and die manufacturers include foam inserts or cardboard inner tubes, which do not have the protective power of the new designed PrimePac solution. The new packaging tubes will be rolled out in the coming months.

Source: I Holland


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.